Literature DB >> 2274262

Evidence for retrograde axonal transport of MPP+ in the rat.

K J Campbell1, M Takada, T Hattori.   

Abstract

Three to 24 h after injecting radioactive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ([3H]MPTP) into the rat striatum, a considerable number of neuronal perikarya were retrogradely radiolabeled in the dorsal raphe, substantia nigra pars compacta and selected regions of the substantia nigra pars reticulata, leaving cells in the ventral tegmental area unlabeled. Pretreatment with tranylcypromine prevented such radiolabel accumulation, indicating that 1-methyl-4-phenylpyridine (MPP+) (but not MPTP) undergoes selective uptake and subsequent retrograde transport in these specific striatal afferent systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2274262     DOI: 10.1016/0304-3940(90)90614-f

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

Authors:  D M Frim; T A Uhler; W R Galpern; M F Beal; X O Breakefield; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

2.  Intraneuronal accumulation and persistence of radiolabel in rat brain following in vivo administration of [3H]-chlorisondamine.

Authors:  H el-Bizri; M G Rigdon; P B Clarke
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

3.  Validity of the MPTP-Treated Mouse as a Model for Parkinson's Disease.

Authors:  Cornelius J H M Klemann; Gerard J M Martens; Geert Poelmans; Jasper E Visser
Journal:  Mol Neurobiol       Date:  2015-02-13       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.